TRP_1170x120_3-8-19

Buprenorphine

Dr. Reddy’s gets FDA approval, launches generic version of Suboxone

Dr. Reddy’s gets FDA approval, launches generic version of Suboxone

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories announced today that it has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching buprenorphine and naloxone sublingual film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone (buprenorphine and